Is a Prognostic Nomogram for Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Useful?
JAMA Surgery · 2023
DOI: 10.1001/jamasurg.2023.0119 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Surgery, 2023. Verfasst von Edward A Levine. Beteiligte Einrichtung: Surgical Oncology Service, Wake Forest University, Winston-Salem, North Carolina. Hauptthemen laut MEDLINE: Pseudomyxoma Peritonei, Peritoneal Neoplasms, Hyperthermia, Induced. Die Arbeit nennt 5 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Surgical Oncology Service, Wake Forest University, Winston-Salem, North Carolina.
Zitieren
APA
Levine, E. A. (2023). Is a Prognostic Nomogram for Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Useful?. JAMA Surgery. https://doi.org/10.1001/jamasurg.2023.0119
Vancouver
Levine EA. Is a Prognostic Nomogram for Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Useful?. JAMA Surgery. 2023. doi:10.1001/jamasurg.2023.0119
BibTeX
@article{Levine2023,
author = {Levine, Edward A},
title = {Is a Prognostic Nomogram for Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Useful?},
journal = {JAMA Surgery},
year = {2023},
doi = {10.1001/jamasurg.2023.0119}
}
EUVIMED